Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple ubiquitous cellular components is a non-specific classification used in pharmacological databases like ChEMBL to describe drugs that do not have a single, discrete molecular target [1]. Instead, these agents interact with a wide variety of cellular structures, including lipid membranes and numerous membrane-bound proteins, often simultaneously [2]. This category is most commonly associated with general anesthetics, such as halothane and isoflurane, which are believed to exert their effects by altering the physical properties of cell membranes or by non-specifically modulating various ion channels [3]. Other substances falling under this umbrella include certain antiseptics and solvents that cause broad chemical or physical disruption to cellular integrity [1]. Because this designation encompasses a vast array of biological molecules rather than a specific protein or receptor, it is not considered a therapeutic target in the traditional sense [1]. The lack of specificity inherent in drugs targeting these components often leads to complex pharmacological profiles and a higher risk of systemic side effects [3]. Consequently, this classification serves more as a catch-all for agents with multi-faceted or poorly defined mechanisms of action rather than a guide for targeted drug development [1]. Sources: [1] ChEMBL Database (Target ID: CHEMBL612111); [2] Franks, N. P. (2008). Nature Reviews Neuroscience; [3] Urban, B. W. (2002). British Journal of Anaesthesia.
Non-specific modulation of lipid bilayer fluidity and multi-target interaction with various membrane-bound proteins and cellular structures [2][3].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple ubiquitous cellular components.